Kishore K Ganji - Founder


Kishore K Ganji is a founding partner and is a Board Member of airis PHARMA. He is on the Board of Directors for Apex Pharmaceuticals, Inc in NJ, USA. He is the Founder and CEO of Astir IT Solutions, Inc. and the driving force behind its remarkable growth. Kishore also serves as CEO of Sysnet Technology Solutions (which Astir acquired in 2011), and as CEO of Astir Analytics. Prior to starting Astir, Kishore worked for PwC, IBM, and Pfizer in the Business Intelligence practices, focusing mainly on Customer Analytics and Health Care. Before this, he worked for Hewlett Packard. In addition to his role as CEO of Astir, Kishore Ganji serves as the President of the Small and Medium Enterprise Consortium (SMEC), a consortium of over 300 technology companies. SMEC promotes sustainable development of the small and mid-sized businesses and is growing rapidly both in the US and outside.

Kishore holds a BS in Electrical Engineering from Osmania University, India. He also has an MBA in Sales and Marketing from the Terry School of Business, University of Georgia, USA. In addition, he was recognized by NJBIZ as one of the top Forty under 40 high-achieving business leaders in New Jersey in 2008, and in 2010 was a finalist in Ernst & Young Entrepreneur of the Year award.

Dr. Mohan R Patalolla - Founder


Dr. Mohan R Patalolla is a founding partner of airis PHARMA. He is the chairman of the Board of Directors for Apex Pharmaceuticals, Inc in NJ, USA. He has a PhD degree in Computer Oriented Numerical Methods and also has a MS in Computer Science and Engineering.

Dr. Patalolla also is a founder and Chief Executive Officer of Innovative Information Technologies, Inc., a software consulting and services company located in Edison, NJ, USA.

Chander Kazipeta - M.Pharm – Director (Head) - Regulatory/Quality/Supply Chain/Commercial Launch


Mr. Chander Kazipeta has over 17 years of regulatory experience in the development of generic products for USFDA, EU, TGA, MEDSAFE, MCC, and ROW markets. He has overall experience in the filing of more than 50 generic product applications in his carrier and also has international work experience at potters bar, London. He has experience in working with MNCs like Strides, Actavis, and Mylan with larger groups in the Regulatory Affairs department, and have been closely interacted with cross-functional departments right from sourcing of drug substance through Drug Product and analytical method development/Validation, manufacturing of exhibit batches, Clinical bio studies and filing ANDAs in eCTD through ESG to USFDA. He does have experience in the commercial launch of generic products in the USA.

He has experience in the establishment of the Regulatory Affairs department and leading Quality Control, Quality assurance and is involved in many USFDA audits. He has experience in working with startup companies.

The initial set-up of “Drug Firm Registration”, a secure e-mail account with US FDA and Established Electronic Submission Gateway account and eCTD software account, Registration and annual renewal of drug firm registration through CDER direct, Processing of “eDRL (Drug listing)” after ANDA approval. He has worked on many submissions ANDA and MAA through DCP, MRP, Re-peat MRP application process in paper or electronic (eCTD), Nees (Non-eCTD) formats including various modules to various health agencies.

He has experience in the design and implementation of regulatory documents about diverse dosage forms. He also is well versed with post-approval changes for different markets.

He has M. Pharm (Industrial Pharmacy) from Annamalai University, Tamil Nadu, India and B. Pharm from Kakatiya University, Warangal, India.

Nagaraj Basappa Amminbavi - M.Pharm – Director (Head) - Research and Development


Mr. Nagaraj Basappa Amminbavi spearheads the research and development division of the company and has more than 17 years of rich work experience in the development of New Drug and Generic Products for USFDA, PMDA, EU, TGA, MEDSAFE, MCC, and ROW markets. He leads the team of highly accomplished scientific talent to deliver various complex and niche dosage forms. Before joining airis PHARMA, he was Deputy General Manager of Formulation research at Mylan and served more than a decade.

Earlier to Mylan, he also worked in reputed companies like Strides, Dr. Reddy’s Laboratories where he gained predominant experience in handling research activities of products for Regulated Markets. His passion for research has helped him expand his horizons across Solid oral, Liquid, and Injectable dosage forms for various regulated markets.

His quest for perfection and relentless focus has led to diversified development and had a credit of filing more than 50 ANDAs with USFDA across various dosage forms and over 20 different products with Europe, PMDA, and Australia.

His strong scientific skills and passion for development give him an edge with complete end-to-end visibility, right from due diligence on product selection to product launch activities.

He has Masters in Pharmaceutics from Manipal College of Pharmaceutical Sciences, India. He is also the lead inventor in scores of granted and application patents and has published many national and international papers and holds about 15 patents to his credit.

Copyright © 2021, airis PHARMA.com. All rights reserved.
Menu Title